Impact of diabetes on serum biomarkers in heart failure with preserved ejection fraction: insights from the TOPCAT trial

Abstract Aims Diabetes mellitus (DM) is common in heart failure with preserved ejection fraction (HFpEF). Patients with DM and heart failure with reduced ejection fraction have higher levels of cardiac, profibrotic, and proinflammatory biomarkers relative to non‐diabetics. Limited data are available...

Descripció completa

Dades bibliogràfiques

Autors principals:	Corrado De Marco, Brian L. Claggett, Simon deDenus, Michael R. Zile, Thao Huynh, Akshay S. Desai, Martin G. Sirois, Scott D. Solomon, Bertram Pitt, Jean L. Rouleau, Marc A. Pfeffer, Eileen O'Meara
Format:	Artigo
Idioma:	Inglês
Publicat:	Oxford University Press 2021-04-01
Col·lecció:	ESC Heart Failure
Matèries:	Heart failure Preserved left ventricular function Diabetes Biomarker Spironolactone
Accés en línia:	https://doi.org/10.1002/ehf2.13153
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!